CRNX - Crinetics Pharmaceuticals EPS misses by $0.06 beats on revenue November, 12 2019 04:47 PM Crinetics Pharmaceuticals Inc. Crinetics Pharmaceuticals (NASDAQ:CRNX): Q3 GAAP EPS of -$0.60 misses by $0.06.More news on: Crinetics Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...